Modeling energy intake and body weight effects of a long-acting amylin analogue
Autor: | Jens Markus Borghardt, Jolanta Skarbaliene, Tamara Baader-Pagler, Stefan Scheuerer, Maria Alexandrovna Deryabina, Annika Brings, Wolfgang Rist |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Amylin 030209 endocrinology & metabolism Peptide hormone Diet High-Fat Rats Sprague-Dawley 03 medical and health sciences 0302 clinical medicine Drug tolerance Internal medicine Animals Medicine Obesity Dosing Rats Wistar Pharmacology business.industry Body Weight medicine.disease Islet Amyloid Polypeptide Rats 030104 developmental biology Endocrinology Drug development Pharmacodynamics Female Anti-Obesity Agents Energy Intake business Homeostasis |
Zdroj: | Journal of Pharmacokinetics and Pharmacodynamics. 45:215-233 |
ISSN: | 1573-8744 1567-567X |
Popis: | The inhibitory effect of anti-obesity drugs on energy intake (EI) is counter-acted by feedback regulation of the appetite control circuit leading to drug tolerance. This complicates the design and interpretation of EI studies in rodents that are used for anti-obesity drug development. Here, we investigated a synthetic long-acting analogue of the appetite-suppressing peptide hormone amylin (LAMY) in lean and diet-induced obese (DIO) rats. EI and body weight (BW) were measured daily and LAMY concentrations in plasma were assessed using defined time points following subcutaneous administration of the LAMY at different dosing regimens. Overall, 6 pharmacodynamic (PD) studies including a total of 173 rats were considered in this evaluation. Treatment caused a dose-dependent reduction in EI and BW, although multiple dosing indicated the development of tolerance over time. This behavior could be adequately described by a population model including homeostatic feedback of EI and a turnover model describing the relationship between EI and BW. The model was evaluated by testing its ability to predict BW loss in a toxicology study and was utilized to improve the understanding of dosing regimens for obesity therapy. As such, the model proved to be a valuable tool for the design and interpretation of rodent studies used in anti-obesity drug development. |
Databáze: | OpenAIRE |
Externí odkaz: |